Research Fellowship Grant Application supports postdoctoral and junior faculty investigators studying thalassemia and its complications to improve understanding or treatment and benefit patients.
Applications and reference letters are now due February 1, 2027, replacing February 9, 2026. The award period shifts from July 1, 2026–June 30, 2027 to July 1, 2027–June 30, 2028; notifications move from May 2026 to May 2027, and forms and funder acknowledgment details also changed.
Funder: Thalassemia Foundation of America (formerly Cooley’s Anemia Foundation)
Due Dates: February 1, 2027 (Applications, references, and renewals) | June 30, 2027 (Non-renewing first-year fellows’ reports) | June 30, 2028 (Second-year fellows’ final reports)
Funding Amounts: Up to $50,000 per year for one year, renewable for a second year
Summary: Supports postdoctoral and junior faculty investigators studying the understanding or treatment of thalassemia and its complications.
Key Information: Postdoctoral applicants cannot hold faculty positions; junior faculty must have completed fewer than five years as assistant professors.
The Thalassemia Foundation of America, formerly Cooley’s Anemia Foundation, offers research fellowships to national and international clinical and basic science investigators at the postdoctoral or junior faculty level. Projects must focus on understanding or treating thalassemia or a related complication, with a clear explanation of how the work will benefit patients.
Areas of interest include globin gene regulation, transfer, and expression; fetal hemoglobin production; hematopoietic stem cells; bone marrow transplantation; iron chelation and overload; endocrine and cardiac disorders; and transfusion therapy and its complications. The Foundation encourages feasible projects whose scope and timeline fit the award period, are distinct from the group’s other funded research, and address potential pitfalls and alternative approaches.